These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24872863)

  • 21. Induced Pluripotent Stem Cells: The Most Versatile Source for Stem Cell Therapy.
    Glicksman MA
    Clin Ther; 2018 Jul; 40(7):1060-1065. PubMed ID: 30049501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical potentials of human pluripotent stem cells.
    Mora C; Serzanti M; Consiglio A; Memo M; Dell'Era P
    Cell Biol Toxicol; 2017 Aug; 33(4):351-360. PubMed ID: 28176010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene Editing in Human Pluripotent Stem Cells: Recent Advances for Clinical Therapies.
    Şişli HB; Hayal TB; Seçkin S; Şenkal S; Kıratlı B; Şahin F; Doğan A
    Adv Exp Med Biol; 2020; 1237():17-28. PubMed ID: 31728915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine.
    Sabapathy V; Kumar S
    J Cell Mol Med; 2016 Aug; 20(8):1571-88. PubMed ID: 27097531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine.
    Revilla A; González C; Iriondo A; Fernández B; Prieto C; Marín C; Liste I
    J Tissue Eng Regen Med; 2016 Nov; 10(11):893-907. PubMed ID: 25758460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of thyroid follicular cells from pluripotent stem cells: potential for regenerative medicine.
    Sewell W; Lin RY
    Front Endocrinol (Lausanne); 2014; 5():96. PubMed ID: 24995001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of companion animal pluripotent stem cells.
    Paterson YZ; Kafarnik C; Guest DJ
    Cytometry A; 2018 Jan; 93(1):137-148. PubMed ID: 28678404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hurdles to clinical translation of human induced pluripotent stem cells.
    Neofytou E; O'Brien CG; Couture LA; Wu JC
    J Clin Invest; 2015 Jul; 125(7):2551-7. PubMed ID: 26132109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Induced pluripotent stem cells. A new resource in modern medicine].
    Liebau S; Stockmann M; Illing A; Seufferlein T; Kleger A
    Internist (Berl); 2014 Apr; 55(4):460-9. PubMed ID: 24553769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of human organs in pigs via interspecies blastocyst complementation.
    Wu J; Platero Luengo A; Gil MA; Suzuki K; Cuello C; Morales Valencia M; Parrilla I; Martinez CA; Nohalez A; Roca J; Martinez EA; Izpisua Belmonte JC
    Reprod Domest Anim; 2016 Oct; 51 Suppl 2():18-24. PubMed ID: 27762052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.
    Budniatzky I; Gepstein L
    Stem Cells Transl Med; 2014 Apr; 3(4):448-57. PubMed ID: 24591731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Stem Cell Derivatives Retain More Open Epigenomic Landscape When Derived from Pluripotent Cells than from Tissues.
    Parsons XH
    J Regen Med; 2013 Jan; 1(2):. PubMed ID: 23936871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
    Shtrichman R; Germanguz I; Itskovitz-Eldor J
    Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.
    Lee H; Park J; Forget BG; Gaines P
    Regen Med; 2009 Sep; 4(5):759-69. PubMed ID: 19761400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal Stem and Progenitor Cells in Regeneration: Tissue Specificity and Regenerative Potential.
    Rohban R; Pieber TR
    Stem Cells Int; 2017; 2017():5173732. PubMed ID: 28286525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Pluripotent Stem Cells: Applications and Challenges for Regenerative Medicine and Disease Modeling.
    Miranda CC; Fernandes TG; Diogo MM; Cabral JMS
    Adv Biochem Eng Biotechnol; 2020; 171():189-224. PubMed ID: 31740987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering Tissues from Induced Pluripotent Stem Cells.
    Loskill P; Huebsch N
    Tissue Eng Part A; 2019 May; 25(9-10):707-710. PubMed ID: 31030627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Pluripotent Stem Cells for Spinal Cord Injury.
    Farzaneh M; Anbiyaiee A; Khoshnam SE
    Curr Stem Cell Res Ther; 2020; 15(2):135-143. PubMed ID: 31656156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of patient-specific hematopoietic stem and progenitor cell grafts from pluripotent stem cells, in vitro.
    Klump H; Teichweyde N; Meyer C; Horn PA
    Curr Mol Med; 2013 Jun; 13(5):815-20. PubMed ID: 23642062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.